<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04950959</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-REG-01-2020</org_study_id>
    <nct_id>NCT04950959</nct_id>
  </id_info>
  <brief_title>XACT ACE Observational Registry</brief_title>
  <official_title>Observational Post-Market Study of the XACT ACE Robotic System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xact Robotics Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xact Robotics Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compile real world data on the use of the XACT ACE Robotic System&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this observational post-market study is to compile real world data on the use&#xD;
      of the XACT ACE Robotic System in subjects undergoing CT guided, minimally invasive&#xD;
      percutaneous procedures.&#xD;
&#xD;
      The objectives are to 1) evaluate the proportion of procedures in which the instrument&#xD;
      reached the pre-defined target, based on the physician's determination and CT imaging&#xD;
      confirmation, 2) To evaluate system accuracy defined as the measured distance from the tip of&#xD;
      the instrument to the target location at the at the end of the instrument insertion, and 3)&#xD;
      Incidence of intra- and post-procedural adverse events.&#xD;
&#xD;
      Up to 500 patients will be enrolled in this multicenter, nonrandomized, single arm registry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Proportion of successful procedures</measure>
    <time_frame>1 hour</time_frame>
    <description>To evaluate the proportion of procedures in which the instrument reached the pre-defined target based on the physician's determination and CT imaging confirmation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>System accuracy</measure>
    <time_frame>1 hour</time_frame>
    <description>To evaluate system accuracy defined as the measured distance from the tip of the instrument to the target location at the end of the instrument insertion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Safety</measure>
    <time_frame>2 hours post-procedure</time_frame>
    <description>Incidence of intra- and post-procedural events</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Tumors</condition>
  <arm_group>
    <arm_group_label>All subjects</arm_group_label>
    <description>Subjects undergoing CT-guided, minimally invasive percutaneous procedures in an interventional radiology setting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T</intervention_name>
    <description>The system is used for trajectory planning and is intended to assist the physician in the positioning of an instrument, such as a needle, where CT imaging is used for target trajectory planning and intraoperative tracking. The XACT ACE Robotic System uses a computerized quantitative guidance system, which provides real-time, accurate needle guidance, including advancement and steering of the needle from the entry point on the subject's body to the target point within the body.</description>
    <arm_group_label>All subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects undergoing CT guided, minimally invasive percutaneous procedures in an&#xD;
        interventional radiology setting.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. â‰¥ 18 years of age&#xD;
&#xD;
          2. Subjects undergoing CT-guided, minimally invasive percutaneous procedures in the&#xD;
             interventional radiology suite&#xD;
&#xD;
          3. Subject is willing to sign informed consent for the purposes of data collection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. No exclusion criteria other than listed in the product Instructions for Use (IFU)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mark Macedo</last_name>
    <role>Study Director</role>
    <affiliation>XACT Robotics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Macedo</last_name>
    <phone>5082076505</phone>
    <email>mark.macedo@xactrobotics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sarasota Interventional Radiology</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Belligan, RN</last_name>
      <phone>941-378-3231</phone>
      <email>clyman@sivr.net</email>
    </contact>
    <investigator>
      <last_name>Gerald Grubbs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CT-guided percutaneous procedure</keyword>
  <keyword>Percutaneous biopsy</keyword>
  <keyword>XACT ACE Robotic System</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

